These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9503180)

  • 21. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
    Ellison KE; Gandhi G
    Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction.
    Schmidt G; Malik M; Barthel P; Schneider R; Ulm K; Rolnitzky L; Camm AJ; Bigger JT; Schömig A
    Lancet; 1999 Apr; 353(9162):1390-6. PubMed ID: 10227219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amiodarone and post-MI patients.
    Nademanee K; Singh BN; Stevenson WG; Weiss JN
    Circulation; 1993 Aug; 88(2):764-74. PubMed ID: 7687937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS).
    Burkart F; Pfisterer M; Kiowski W; Follath F; Burckhardt D
    J Am Coll Cardiol; 1990 Dec; 16(7):1711-8. PubMed ID: 2254558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of effect of amiodarone on survival after extensive infarction. Polish Amiodarone Trial.
    Budaj A; Kokowicz P; Smielak-Korombel W; Kuch J; Krzemińska-Pakuøa M; Maciejewicz J; Nartowicz E; Zaleska T; Dyduszyński A; Ceremuzyński L
    Coron Artery Dis; 1996 Apr; 7(4):315-9. PubMed ID: 8853584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalent low-frequency oscillation of heart rate: novel predictor of mortality after myocardial infarction.
    Wichterle D; Simek J; La Rovere MT; Schwartz PJ; Camm AJ; Malik M
    Circulation; 2004 Sep; 110(10):1183-90. PubMed ID: 15313954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Irvine J; Baker B; Smith J; Jandciu S; Paquette M; Cairns J; Connolly S; Roberts R; Gent M; Dorian P
    Psychosom Med; 1999; 61(4):566-75. PubMed ID: 10443767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-arrhythmia therapy after myocardial infarct: preliminary results of EMIAT and CAMIAT studies].
    Kuck KH
    Z Kardiol; 1996; 85 Suppl 6():107-13. PubMed ID: 9064953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmic therapy in the post-infarction setting: update from major amiodarone studies.
    Cairns JA
    Int J Clin Pract; 1998 Sep; 52(6):422-4. PubMed ID: 9894381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function.
    Pfisterer M; Kiowski W; Burckhardt D; Follath F; Burkart F
    Am J Cardiol; 1992 Jun; 69(17):1399-402. PubMed ID: 1590226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of patients with risk of sudden death. The amiodarone example].
    Djian J
    Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction.
    Rodríguez LM; Sternick EB; Smeets JL; Timmermans C; den Dulk K; Oreto G; Wellens HJ
    Heart; 1996 Jan; 75(1):23-8. PubMed ID: 8624866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone: a late comer.
    Futterman LG; Lemberg L
    Am J Crit Care; 1997 May; 6(3):233-9. PubMed ID: 9131203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction.
    Li T; Wei X; Watkins AC; Sanchez PG; Wu ZJ; Griffith BP
    J Surg Res; 2013 Nov; 185(1):152-8. PubMed ID: 23773712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis.
    Hallstrom AP; Wyse DG; McAnulty J; ;
    J Interv Card Electrophysiol; 2008 Dec; 23(3):159-66. PubMed ID: 18810620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Pinski SL
    Lancet; 1997 Jun; 349(9067):1768-9; author reply 1769-70. PubMed ID: 9193400
    [No Abstract]   [Full Text] [Related]  

  • 37. Amiodarone rescue therapy for severe decompensated heart failure initially unsuitable for beta-blockers.
    Choo DC; Huiskes B; Jones J; Fabbri S; Hawkins LA; Chatterjee K; De Marco T; Heywood JT
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):187-92. PubMed ID: 14506543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Norris RM
    Lancet; 1997 Jun; 349(9067):1767. PubMed ID: 9193396
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical efficacy of amiodarone.
    Nolan PE; Nappi J; Pollak PT
    Pharmacotherapy; 1998; 18(6 Pt 2):127S-137S. PubMed ID: 9855345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of invasive and noninvasive tests in high risk patients treated with amiodarone after acute myocardial infarction.
    Pedretti RF; Migliori GB; Mapelli V; Daniele G; Podrid PJ; Tramarin R
    J Am Coll Cardiol; 1998 Jun; 31(7):1481-9. PubMed ID: 9626823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.